-
Mashup Score: 2FDA Approves Nirsevimab-alip to Prevent RSV in Infants, Toddlers - 1 year(s) ago
The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1
Effective implementation of the Inflation Reduction Act may allow legislators to shift their focus toward controversial pharmacy benefit manager practices, according to a panel discussion during the ATOPP Summit.
Source: Pharmacy TimesCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @oncologyCOA: Inflation Reduction Act, EOM, PBM Reform Remain Hot Topics on Capitol Hill - from @Pharmacy_Times https://t.co/Yvxpy7zF9b
-
-
Mashup Score: 02023 OTC Guide - 1 year(s) ago
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
This year’s OTC Guide is available! Learn what your colleagues are recommending to patients and stay ahead of pharmacy best practices >> https://t.co/HjS5CIGYLm https://t.co/lo4sCBxsve
-
-
Mashup Score: 2
Study suggests supplemental oxygen may improve cognitive functions that are vital in motor learning, which can be important for people with neurological conditions or trauma.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Study suggests supplemental oxygen may improve cognitive functions that are vital in motor learning, which can be important for people with neurological conditions or trauma. #neurology Read More: https://t.co/yrGfiDjHOc
-
-
Mashup Score: 0Treatment of HER2-Low Breast Cancer Impacts Oncology Landscape - 1 year(s) ago
Because of its prevalence in approximately 50% of breast cancers, the outcomes of HER2-low treatment have a significant impact on patient outcomes.
Source: Pharmacy TimesCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Until recently, treatment for HER2 low disease has been limited to conventional cytotoxic therapies, according to our Neelam Patel. Here, she discusses new developments in treating hormone receptor positive #BreastCancer: https://t.co/DpwtMMqwED @Pharmacy_Times #EndCancer
-
-
Mashup Score: 0Missed or Delayed Pediatric Preventative Care During COVID-19 Pandemic Influenced By Race, Enabling Factors - 1 year(s) ago
Study among the first to examine delayed or missed pediatric preventative care during COVID-19 that considers determinants, race, and ethnic group, according to the authors.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
More than one-quarter of children (27.6%) missed or delayed a preventative check-up because of the COVID-19 pandemic, according to research published in @JAMANetworkOpen. Read More: https://t.co/w38CR1H22I
-
-
Mashup Score: 1
Quality standards and national regulation help to establish its role as medicine.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Medical research on #cannabis that could support its characterization has suffered because of federal prohibition that limits the scope and methods of these studies. Read More: https://t.co/t4aT7ku11d https://t.co/oGaLEe7PUP
-
-
Mashup Score: 1Navigating the Path to Safe Compounding in Health Systems - 1 year(s) ago
Drug shortages have led to increased use of compounding pharmacy.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Although compounding pharmacies create versions of commercially available drugs under certain circumstances, state regulators have raised concerns about using unapproved forms of drugs such as semaglutide. #pharmacy Read More: https://t.co/M7djAMgMgt
-
-
Mashup Score: 0FDA Accepts New Drug Application for Zanubrutinib Combination for R/R Follicular Lymphoma - 1 year(s) ago
Zanubrutinib combined with obinutuzumab was previously granted both Fast Track and Orphan drug designations for patients with relapsed or refractory follicular lymphoma.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Zanubrutinib combined with obinutuzumab was previously granted both Fast Track and Orphan drug designations for patients with relapsed or refractory follicular #lymphoma. Read More: https://t.co/s8GQ6gA791
-
-
Mashup Score: 2
MicroRNA has shown the potential to more effectively and accurately identify C. difficile infections and manage it after diagnosis.
Source: Pharmacy TimesCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
MicroRNA has shown the potential to more effectively and accurately identify C. difficile infections and manage it after diagnosis. Read More: https://t.co/Hbpqxnh0I9
-
The FDA have approved nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) for the prevention of RSV-associated lower respiratory tract disease in neonates and infants born during or entering their first RSV season. #RSV Read More: https://t.co/GpGS6VC44h